Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Annexon, Inc.ANNX · Entity 5011 | EVP & Chief Scientific Officer | July 11, 2022 | July 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Annexon, Inc.
Report date July 11, 2022 · Filed July 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,188 |
Reported balance
After 2022-07-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-11 · Grant · Acquired 4,688 · Balance 17,188 F1: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on July 11th of each year, with the first 1/3rd vesting on July 11, 2023. F2: Includes 17,188 RSUs. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.91 · Expires 2032-07-11 | Direct | 37,500 |
Reported balance
After 2022-07-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-11 · Grant · Acquired 37,500 · Balance 37,500 F3: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on July 11th of each year, with the first 1/3rd vesting on July 11, 2023.
F2: Includes 17,188 RSUs.
F3: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 11, 2022 Filed Jul 13, 2022 23:40 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001567619-22-013997 · doc1.xml · derivative · entry 2 Mattheakis Larry · CIK 0001885081 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2032-07-11 F3 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 23:40 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-013997 · doc1.xml · nonDerivative · entry 1 Mattheakis Larry · CIK 0001885081 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,188 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on July 11th of each year, with the first 1/3rd vesting on July 11, 2023. F2 · balance_after: Includes 17,188 RSUs. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 23:37 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001567619-22-013996 · doc1.xml · derivative · entry 2 Mattheakis Larry · CIK 0001885081 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2032-07-11 F3 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 23:37 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-013996 · doc1.xml · nonDerivative · entry 1 Mattheakis Larry · CIK 0001885081 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,188 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on July 11th of each year, with the first 1/3rd vesting on July 11, 2023. F2 · balance_after: Includes 17,188 RSUs. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:35 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $6.94 | $0.00 |
DisclosureSEC source: 0001567619-22-004611 · doc1.xml · derivative · entry 2 Mattheakis Larry · CIK 0001885081 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-11 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:35 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-004611 · doc1.xml · nonDerivative · entry 1 Mattheakis Larry · CIK 0001885081 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 11 of each year, with the first 1/3rd vesting on February 11, 2023. F2 · balance_after: Includes 12,500 RSUs. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 22:31 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $18.61 | $0.00 |
DisclosureSEC source: 0001567619-21-017862 · doc1.xml · derivative · entry 1 Mattheakis Larry · CIK 0001885081 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2031-09-30 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from September 30, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.